A S Lihn

Summary

Country: Denmark

Publications

  1. ncbi Adiponectin: action, regulation and association to insulin sensitivity
    A S Lihn
    Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus Sygehus, Denmark
    Obes Rev 6:13-21. 2005
  2. ncbi Stimulation of PAI-1 and adipokines by glucose in human adipose tissue in vitro
    G He
    Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital, DK 8000 Aarhus C, Denmark
    Biochem Biophys Res Commun 310:878-83. 2003
  3. ncbi Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines
    G He
    Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus, Denmark
    Eur J Clin Invest 35:583-90. 2005
  4. ncbi Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects
    G He
    Department of Endocrinology and Metabolism C, Aarhus Kommehospital, Aarhus University Hospital, Aarhus C, Denmark
    Horm Metab Res 35:178-82. 2003
  5. ncbi Metformin, but not thiazolidinediones, inhibits plasminogen activator inhibitor-1 production in human adipose tissue in vitro
    G He
    Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital, Aarhus, Denmark
    Horm Metab Res 35:18-23. 2003
  6. ncbi Increased plasma adiponectin in losartan-treated type 1 diabetic patients. a mediator of improved insulin sensitivity?
    S Nielsen
    Medical Departments of Endocrinology and Diabetes, Aarhus University Hospitals, Denmark
    Horm Metab Res 36:194-6. 2004
  7. ncbi Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients
    A S Lihn
    Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital and Faculty of Health Sciences, Aarhus University, DK 8000 Aarhus C, Denmark
    Am J Physiol Endocrinol Metab 284:E443-8. 2003

Detail Information

Publications7

  1. ncbi Adiponectin: action, regulation and association to insulin sensitivity
    A S Lihn
    Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus Sygehus, Denmark
    Obes Rev 6:13-21. 2005
    ..In summary, adiponectin in addition to possible anti-inflammatory and anti-atherogenic effects appears to be an insulin enhancer, with potential as a new pharmacologic treatment modality of the metabolic syndrome and type 2 diabetes...
  2. ncbi Stimulation of PAI-1 and adipokines by glucose in human adipose tissue in vitro
    G He
    Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital, DK 8000 Aarhus C, Denmark
    Biochem Biophys Res Commun 310:878-83. 2003
    ....
  3. ncbi Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines
    G He
    Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus, Denmark
    Eur J Clin Invest 35:583-90. 2005
    ..CONCLUSION: Plasma PAI-1 is increased in HALS patients and it is suggested that dysregulation of the TNF-system (high TNFalpha and high sTNFR1) may play a role in up-regulating PAI-1 in HALS...
  4. ncbi Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects
    G He
    Department of Endocrinology and Metabolism C, Aarhus Kommehospital, Aarhus University Hospital, Aarhus C, Denmark
    Horm Metab Res 35:178-82. 2003
    ..Finally, PAI-1 production in adipose tissue from obese women was higher in non-obese women after incubation for 72 h...
  5. ncbi Metformin, but not thiazolidinediones, inhibits plasminogen activator inhibitor-1 production in human adipose tissue in vitro
    G He
    Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital, Aarhus, Denmark
    Horm Metab Res 35:18-23. 2003
    ..Our findings indicate no direct effects of TZDs on PAI-1 secretion, whereas metformin was able to directly inhibit PAI-1 production in human adipose tissue...
  6. ncbi Increased plasma adiponectin in losartan-treated type 1 diabetic patients. a mediator of improved insulin sensitivity?
    S Nielsen
    Medical Departments of Endocrinology and Diabetes, Aarhus University Hospitals, Denmark
    Horm Metab Res 36:194-6. 2004
  7. ncbi Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients
    A S Lihn
    Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital and Faculty of Health Sciences, Aarhus University, DK 8000 Aarhus C, Denmark
    Am J Physiol Endocrinol Metab 284:E443-8. 2003
    ..Adiponectin mRNA levels are positively correlated with insulin sensitivity in control subjects but not in FDR. These findings indicate dysregulation of adiponectin gene expression in FDR...